Technology area: Biotechnology & Pharmaceuticals
25 pending office actions • 21 art units • 24 examiners • 0 of 25 (0%) have an AI response strategy ready • 24 patents granted in the last 365 days
The University of Maryland, Baltimore maintains a significant presence in the Biotechnology & Pharmaceuticals technology area with 25 pending office actions. These actions are distributed across 24 distinct examiners, reflecting a high degree of diversity in the personnel assigned to the university's cases. The technical breadth is further evidenced by the involvement of 20 distinct art units. The 25 pending office actions represent a large and complex prosecution workload.
MINCHELLA, KAITLYN L is the busiest examiner for this portfolio, currently overseeing 2 busiest examiner pending actions. This represents a very low level of concentration, as 24 distinct examiners are involved in the 25 pending office actions. Almost every pending action is being reviewed by a different individual. The 20 distinct art units indicate that the university's research spans a wide array of biological and pharmaceutical disciplines.
Practitioners must be prepared to navigate the specific requirements of 20 different art units, each with its own internal standards. The decentralized nature of the 25 pending office actions means that the university's overall success is not tied to a small group of examiners. Effectively managing 24 distinct examiners requires a highly coordinated approach to ensure consistency across the 20 distinct art units. The 2 busiest examiner pending actions under MINCHELLA, KAITLYN L provide only a minor point of concentration.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (8%) |
| §103 only | 4 (16%) |
| §102 only | 2 (8%) |
| §112 only | 1 (4%) |
| Double-patenting + other | 3 (12%) |
| Multi-statute (no §101) | 13 (52%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MINCHELLA, KAITLYN L | 2 | 26.4% | +21.7% |
| SHI, KATHERINE MENGLIN | 1 | 78.3% | +21.8% |
| WAX, ROBERT A | 1 | 25.7% | +3.9% |
| PATEL, RISHI R | 1 | 82.8% | +2.6% |
| MOSHER, ERIC PARKER | 1 | 100.0% | +0.0% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.4% | +24.3% |
| RAO, SAVITHA M | 1 | 60.7% | +29.7% |
| VARADARAJ, ARCHANA | 1 | 80.0% | +33.3% |
| DEAK, LESLIE R | 1 | 75.4% | +17.8% |
| ALAWADI, SARAH | 1 | 37.7% | +38.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18919564 | USE OF MULTIPHOTON EXCITATION FOR FLUORESCENCE IMAGING OF STAINED CALCIFIED MINERALS | MOSHER, ERIC PARKER | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15028253 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 14d |
| 17774215 | METHODS FOR DISTINGUISHING THE STAGES OF BACTERIAL VAGINOSIS | MCKNIGHT, CIARA A | 19d |
| 15489658 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 21d |
| 19070050 | HEART VALVE REPAIR USING SUTURE KNOTS | SHI, KATHERINE MENGLIN | — |
| 19008900 | BOOSTING OSMOTIC BLOOD-ORGAN BARRIER OPENING FOR IMPROVED DELIVERY OF THERAPEUTICS TO ORGANS | WAX, ROBERT A | — |
| 18984181 | DETECTION OF PHARMACEUTICAL PRODUCT FREEZING HISTORY USING WATER PROTON NMR | PATEL, RISHI R | — |
| 18857231 | SMALL MOLECULE INDUCERS OF CARDIOMYOCYTES TO IMPROVE CARDIAC STRUCTURE AND FUNCTION | WHITE, DAWANNA SHAR-DAY | — |
| 18761250 | DIAGNOSIS AND TREATMENT OF VASODILATORY SHOCK | VARADARAJ, ARCHANA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15028253 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 14d |
| 15489658 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 21d |
| 19070050 | HEART VALVE REPAIR USING SUTURE KNOTS | SHI, KATHERINE MENGLIN | — |
| 18857231 | SMALL MOLECULE INDUCERS OF CARDIOMYOCYTES TO IMPROVE CARDIAC STRUCTURE AND FUNCTION | WHITE, DAWANNA SHAR-DAY | — |
| 18790141 | SMALL MOLECULE INHIBITORS OF GPCR GPR68 AND RELATED RECEPTORS FOR TREATING CANCER, GLIOBLASTOMA, AND OTHER INDICATIONS | RAO, SAVITHA M | — |
| 18761250 | DIAGNOSIS AND TREATMENT OF VASODILATORY SHOCK | VARADARAJ, ARCHANA | — |
| 18739456 | SELF-SEALING CANNULA | DEAK, LESLIE R | — |
| 18593423 | Multifunctional Dental Adhesives and Uses Thereof | ALAWADI, SARAH | — |
| Art Unit | Apps |
|---|---|
| 1627 | 2 |
| 1628 | 2 |
| 1656 | 2 |
| 1685 | 2 |
| 3771 | 1 |
| 1615 | 1 |
| 2858 | 1 |
| 1612 | 1 |
| 1691 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19070050 | HEART VALVE REPAIR USING SUTURE KNOTS | SHI, KATHERINE MENGLIN | 3771 | §103§112 | Non-Final OA | — | Pending | Mar 04, 2025 |
| 19008900 | BOOSTING OSMOTIC BLOOD-ORGAN BARRIER OPENING FOR IMPROVED DELIVERY OF THERAPEUTICS TO ORGANS | WAX, ROBERT A | 1615 | §102§103§112 | Non-Final OA | — | Pending | Jan 03, 2025 |
| 18984181 | DETECTION OF PHARMACEUTICAL PRODUCT FREEZING HISTORY USING WATER PROTON NMR | PATEL, RISHI R | 2858 | §102§112Other | Non-Final OA | — | Pending | Dec 17, 2024 |
| 18919564 | USE OF MULTIPHOTON EXCITATION FOR FLUORESCENCE IMAGING OF STAINED CALCIFIED MINERALS | MOSHER, ERIC PARKER | 1612 | §103DP | Non-Final OA | — | Pending | Oct 18, 2024 |
| 18857231 | SMALL MOLECULE INDUCERS OF CARDIOMYOCYTES TO IMPROVE CARDIAC STRUCTURE AND FUNCTION | WHITE, DAWANNA SHAR-DAY | 1627 | §103§112 | Non-Final OA | — | Pending | Oct 16, 2024 |
| 18790141 | SMALL MOLECULE INHIBITORS OF GPCR GPR68 AND RELATED RECEPTORS FOR TREATING CANCER, GLIOBLASTOMA, AND OTHER INDICATIONS | RAO, SAVITHA M | 1691 | §103DP | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18761250 | DIAGNOSIS AND TREATMENT OF VASODILATORY SHOCK | VARADARAJ, ARCHANA | 1658 | §101§102 | Non-Final OA | — | Pending | Jul 01, 2024 |
| 18739456 | SELF-SEALING CANNULA | DEAK, LESLIE R | 3799 | §102DP | Non-Final OA | — | Pending | Jun 11, 2024 |
| 18593423 | Multifunctional Dental Adhesives and Uses Thereof | ALAWADI, SARAH | 1619 | §103§112 | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18684329 | ENDOSCOPIC, PERCUTANEOUS AND OTHER METHODS FOR DISSOLUTION OF PANCREATIC NECROSIS | RASSAVONG, ERIC | 3781 | §102§103 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18568126 | PROTEOLYSIS TARGETING CHIMERAS AND METHODS OF USE THEREOF | SAMSELL, RILLA MARIE | 1624 | §112 | Non-Final OA | — | Pending | Dec 07, 2023 |
| 18565426 | DUAL WNT SIGNALING PATHWAY INHIBITORS AND AMPK ACTIVATORS FOR TREATMENTS OF DISEASE | ROBINSON, MIKHAIL O'DONNEL | 1627 | §102Other | Non-Final OA | — | Pending | Nov 29, 2023 |
| 18562170 | A BROADLY PROTECTIVE PROPHYLACTIC VACCINE AGAINST PSEUDOMONAS AERUGINOSA | DEVI, SARVAMANGALA | 1645 | §103§112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18345614 | ANGLED TRANSCRANIAL MAGNETIC STIMULATION DEVICE | LANDEEN, BROGAN RANE | 3791 | §103§112 | Final Rejection | — | Pending | Jun 30, 2023 |
| 18265191 | BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX | O DELL, DAVID K | 1621 | §102§112Other | Final Rejection | — | Pending | Jun 02, 2023 |
| 18000471 | GEL FOR USE IN GASTROINTESTINAL ENDOSCOPY AND ENDODERMAL, EPIDERMAL, AND OTHER MUCOSAL USES | BARSKY, JARED | 1628 | §103 | Final Rejection | — | Pending | Dec 01, 2022 |
| 18048731 | DUAL HDAC6/PROTEASOME INHIBITORS, AND METHODS OF USE THEREOF | MCANANY, JOHN D | 1625 | §103 | Non-Final OA | — | Pending | Oct 21, 2022 |
| 17956454 | Electrochemical Method for Detecting Clozapine | OSMAN, SOMMER YOUSEF | 1794 | §103§112 | Non-Final OA | — | Pending | Sep 29, 2022 |
| 17774215 | METHODS FOR DISTINGUISHING THE STAGES OF BACTERIAL VAGINOSIS | MCKNIGHT, CIARA A | 1656 | §101§103 | Non-Final OA | 19d | Pending | May 04, 2022 |
| 17616584 | ADJUVANTS FOR IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | HIBSHMAN, SARAH GRACE | 1693 | §103 | Final Rejection | 34d | Pending | Dec 03, 2021 |
| 17616586 | BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX | CHENG, KAREN | 1623 | §102 | Final Rejection | — | Pending | Dec 03, 2021 |
| 17415344 | ASPARAGINASE-INDUCED GLUTAMINE DEPLETION COMBINED WITH BCL-2 INHIBITION FOR TREATMENT OF HEMATOLOGIC AND SOLID CANCERS | SPANGLER, JOSEPH RANKIN | 1656 | §103 | Final Rejection | — | Pending | Jun 17, 2021 |
| 17056845 | METHODS OF INHIBITING PROINFLAMMATORY NEUROIMMUNE SIGNALING AND TREATING INFLAMMATORY DISORDERS | COPPINS, JANET L | 1628 | §103§112 | Non-Final OA | — | Pending | Nov 19, 2020 |
| 15489658 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 1685 | §103§112 | Final Rejection | 21d | Pending | Apr 17, 2017 |
| 15028253 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 1685 | §102§112Other | Final Rejection | 14d | Pending | Apr 08, 2016 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Maryland, Baltimore has 25 pending office actions as of October 2026, spread across 21 art units and 24 examiners.
Kaitlyn L Minchella has the most, with 2 of University of Maryland, Baltimore's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
